Answers are grounded in this paper and cite their sources.
Compared to twice-weekly surveillance, once-weekly microbiological surveillance reduces costs by 30% with 6% loss in clinically relevant PPM detections. No surveillance reduces costs by 60% with 14% detection loss.
No takes yet. Share an insight, caveat, or question.
Mulier et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: